{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:48:42Z","timestamp":1767174522349,"version":"build-2238731810"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCBZ2024121"],"award-info":[{"award-number":["YCBZ2024121"]}]},{"name":"Guangxi Key Technologies R&D Program","award":["2023AB22055"],"award-info":[{"award-number":["2023AB22055"]}]},{"name":"Central Leading Local Science and Technology Development Fund Project","award":["2023ZYZX1021"],"award-info":[{"award-number":["2023ZYZX1021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00696-6","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:43:46Z","timestamp":1741412626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum IgE in the clinical features and disease outcomes of anti-interferon-\u03b3 autoantibodies syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Ni","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"issue":"3","key":"696_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-023-00933-2","volume":"24","author":"A Cheng","year":"2024","unstructured":"Cheng A, Holland SM. Anti-cytokine autoantibodies: mechanistic insights and disease associations. Nat Rev Immunol. 2024;24(3):161\u201377.","journal-title":"Nat Rev Immunol"},{"key":"696_CR2","doi-asserted-by":"crossref","first-page":"1629258","DOI":"10.1155\/2019\/1629258","volume":"2019","author":"DI Krisnawati","year":"2019","unstructured":"Krisnawati DI, Liu YC, Lee YJ, Wang YT, Chen CL, Tseng PC, Shen TJ, Lin CF. Blockade Effects of Anti-Interferon- (IFN-) \u03b3 Autoantibodies on IFN-\u03b3-Regulated Antimicrobial Immunity. J Immunol Res. 2019;2019:1629258.","journal-title":"J Immunol Res"},{"issue":"8","key":"696_CR3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334.","journal-title":"N Engl J Med"},{"key":"696_CR4","doi-asserted-by":"publisher","unstructured":"Guo J, Ning XQ, Ding JY, Zheng YQ, Shi NN, Wu FY, Lin YK, Shih HP, Ting HT, Liang G et al. Anti-IFN-\u03b3 autoantibodies underlie disseminated Talaromyces marneffei infections. J Exp Med. 2020;217(12):e20190502. https:\/\/doi.org\/10.1084\/jem.20190502.","DOI":"10.1084\/jem.20190502"},{"issue":"8","key":"696_CR5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","volume":"66","author":"A Aoki","year":"2018","unstructured":"Aoki A, Sakagami T, Yoshizawa K, Shima K, Toyama M, Tanabe Y, Moro H, Aoki N, Watanabe S, Koya T, et al. Clinical Significance of Interferon-\u03b3 Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease. Clin Infect Dis. 2018;66(8):1239\u201345.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"696_CR6","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","volume":"38","author":"R D\u00f6ffinger","year":"2004","unstructured":"D\u00f6ffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10-14.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"696_CR7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","volume":"103","author":"C H\u00f6flich","year":"2004","unstructured":"H\u00f6flich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, D\u00f6cke WD, Gr\u00fctz G, Meisel C, Halle E, G\u00f6bel UB, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103(2):673\u20135.","journal-title":"Blood"},{"issue":"8","key":"696_CR8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","volume":"15","author":"UI Wu","year":"2015","unstructured":"Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15(8):968\u201380.","journal-title":"Lancet Infect Dis"},{"key":"696_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijid.2020.02.037","volume":"93","author":"X Liang","year":"2020","unstructured":"Liang X, Si L, Li Y, Zhang J, Deng J, Bai J, Li M, He Z. Talaromyces marneffei infection relapse presenting as osteolytic destruction followed by suspected nontuberculous mycobacterium infection during 6 years of follow-up: A case update. Int J Infect Dis. 2020;93:208\u201310.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"696_CR10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40121-023-00801-5","volume":"12","author":"Q Yu","year":"2023","unstructured":"Yu Q, Wei M, Xiao R, Liang X, Liang S, Ma N, Wu S, Ning Y, Deng J, Yang M, et al. Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study. Infect Dis Ther. 2023;12(5):1283\u201397.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"696_CR11","doi-asserted-by":"crossref","first-page":"2396887","DOI":"10.1080\/22221751.2024.2396887","volume":"13","author":"S Liang","year":"2024","unstructured":"Liang S, Liang H, Huang X, Liang X, Chen N, Xiao R, Luo Z, Chen Q, Zhong X, Deng J, et al. Clinical immunological characteristics of anti-interferon-\u03b3 autoantibodies syndrome: a 3 year prospective cohort study. Emerg Microbes Infect. 2024;13(1):2396887.","journal-title":"Emerg Microbes Infect"},{"issue":"36","key":"696_CR12","doi-asserted-by":"crossref","first-page":"e21738","DOI":"10.1097\/MD.0000000000021738","volume":"99","author":"XN Liang","year":"2020","unstructured":"Liang XN, Bin YF, Lai GT, Li YH, Zhang JQ, Zhong XN, Bai J, Li MH, Deng JM, He ZY. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report. Medicine (Baltimore). 2020;99(36):e21738.","journal-title":"Medicine (Baltimore)"},{"key":"696_CR13","first-page":"689","volume":"9","author":"M Maurer","year":"2018","unstructured":"Maurer M, Altrichter S, Schmetzer O, Scheffel J, Church MK, Metz M. Immunoglobulin E-Mediated Autoimmunity Front Immunol. 2018;9:689.","journal-title":"Immunoglobulin E-Mediated Autoimmunity Front Immunol"},{"issue":"6","key":"696_CR14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jaci.2016.04.007","volume":"137","author":"MA Sanjuan","year":"2016","unstructured":"Sanjuan MA, Sagar D, Kolbeck R. Role of IgE in autoimmunity. J Allergy Clin Immunol. 2016;137(6):1651\u201361.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"696_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13075-020-02338-1","volume":"22","author":"J Zhou","year":"2020","unstructured":"Zhou J, Peng Y, Peng L, Wu D, Li J, Jiang N, Li J, Lu H, Liu Z, Luo X, et al. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study. Arthritis Res Ther. 2020;22(1):255.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"696_CR16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","volume":"17","author":"J Henault","year":"2016","unstructured":"Henault J, Riggs JM, Karnell JL, Liarski VM, Li J, Shirinian L, Xu L, Casey KA, Smith MA, Khatry DB, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. 2016;17(2):196\u2013203.","journal-title":"Nat Immunol"},{"key":"696_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","volume":"177","author":"M Og\u0142uszka","year":"2019","unstructured":"Og\u0142uszka M, Orzechowska M, J\u0119droszka D, Witas P, Bednarek AK. Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Programs Biomed. 2019;177:133\u20139.","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"696_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","volume":"12","author":"N van Beek","year":"2016","unstructured":"van Beek N, Schulze FS, Zillikens D, Schmidt E. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases. Expert Rev Clin Immunol. 2016;12(3):267\u201377.","journal-title":"Expert Rev Clin Immunol"},{"key":"696_CR19","doi-asserted-by":"crossref","unstructured":"Permin H, Wiik A. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol Microbiol Scand C. 1978;86c(5):245\u2013249.","DOI":"10.1111\/j.1699-0463.1978.tb02587.x"},{"key":"696_CR20","doi-asserted-by":"publisher","unstructured":"Peel JN, Yang R, Le Voyer T, Gervais A, Rosain J, Bastard P, Behere A, Cederholm A, Bodansky A, Seeleuthner Y, et al. Neutralizing IFN-\u03b3 autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals. J Clin Invest. 2024;134(8):e178263. https:\/\/doi.org\/10.1172\/JCI178263.","DOI":"10.1172\/JCI178263"},{"issue":"7","key":"696_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1535370220981579","volume":"246","author":"K Chawansuntati","year":"2021","unstructured":"Chawansuntati K, Rattanathammethee K, Wipasa J. Minireview: Insights into anti-interferon-\u03b3 autoantibodies. Exp Biol Med (Maywood). 2021;246(7):790\u20135.","journal-title":"Exp Biol Med (Maywood)"},{"key":"696_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2019.02.006","volume":"338","author":"HK Yoon","year":"2019","unstructured":"Yoon HK, Shim YS, Kim PH, Park SR. The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1\/IgE class switching and germline \u03b5 transcription through the induction of BCL6 expression in B cells. Cell Immunol. 2019;338:1\u20138.","journal-title":"Cell Immunol"},{"issue":"5","key":"696_CR23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2022.05.023","volume":"150","author":"M Volkov","year":"2022","unstructured":"Volkov M, Coppola M, Huizinga R, Eftimov F, Huizinga TWJ, van der Kooi AJ, Oosten LEM, Raaphorst J, Rispens T, Sciarrillo R, et al. Comprehensive overview of autoantibody isotype and subclass distribution. J Allergy Clin Immunol. 2022;150(5):999\u20131010.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"696_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08916934.2017.1280670","volume":"50","author":"R Ettinger","year":"2017","unstructured":"Ettinger R, Karnell JL, Henault J, Panda SK, Riggs JM, Kolbeck R, Sanjuan MA. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses. Autoimmunity. 2017;50(1):25\u201336.","journal-title":"Autoimmunity"},{"issue":"12","key":"696_CR25","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/all.15843","volume":"78","author":"N Charles","year":"2023","unstructured":"Charles N, Kortekaas-Krohn I, Kocaturk E, Scheffel J, Altrichter S, Steinert C, Xiang YK, Gutermuth J, Reber LL, Maurer M. Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases. Allergy. 2023;78(12):3118\u201335.","journal-title":"Allergy"},{"key":"696_CR26","doi-asserted-by":"crossref","first-page":"1112917","DOI":"10.3389\/fphar.2023.1112917","volume":"14","author":"A Olewicz-Gawlik","year":"2023","unstructured":"Olewicz-Gawlik A, Kowala-Piaskowska A. Self-reactive IgE and anti-IgE therapy in autoimmune diseases. Front Pharmacol. 2023;14:1112917.","journal-title":"Front Pharmacol"},{"issue":"1","key":"696_CR27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12879-024-09003-x","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Yu Q, Liang H, Wu S, Liang S, Liang X, He Z. Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-\u03b3 autoantibodies: a case report. BMC Infect Dis. 2024;24(1):78.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"696_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000347112","volume":"226","author":"JF Chan","year":"2013","unstructured":"Chan JF, Trendell-Smith NJ, Chan JC, Hung IF, Tang BS, Cheng VC, Yeung CK, Yuen KY. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet\u2019s syndrome and beyond. Dermatology. 2013;226(2):157\u201366.","journal-title":"Dermatology"},{"issue":"12","key":"696_CR29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/ijd.16870","volume":"62","author":"P Pattanaprichakul","year":"2023","unstructured":"Pattanaprichakul P, Leeyaphan C, Angkasekwinai N, Bunyaratavej S, Senawong S, Sereeaphinan C, Munprom K. Prevalence and clinical manifestations of cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies: an eight-year retrospective study. Int J Dermatol. 2023;62(12):1506\u201310.","journal-title":"Int J Dermatol"},{"issue":"1","key":"696_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","volume":"29","author":"J Vandewalle","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. 2018;29(1):42\u201354.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"696_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","volume":"21","author":"MD Taves","year":"2021","unstructured":"Taves MD, Ashwell JD. Glucocorticoids in T cell development, differentiation and function. Nat Rev Immunol. 2021;21(4):233\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"696_CR32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI111757","volume":"75","author":"TR Cupps","year":"1985","unstructured":"Cupps TR, Gerrard TL, Falkoff RJ, Whalen G, Fauci AS. Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. J Clin Invest. 1985;75(2):754\u201361.","journal-title":"J Clin Invest"},{"issue":"1","key":"696_CR33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12879-021-06255-9","volume":"21","author":"ZM Chen","year":"2021","unstructured":"Chen ZM, Li ZT, Li SQ, Guan WJ, Qiu Y, Lei ZY, Zhan YQ, Zhou H, Lin S, Wang X, et al. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-\u03b3 immunodeficiency: a prospective cohort study. BMC Infect Dis. 2021;21(1):587.","journal-title":"BMC Infect Dis"}],"updated-by":[{"DOI":"10.1186\/s12865-025-00704-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000}}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00696-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T14:28:19Z","timestamp":1743172099000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00696-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00696-6","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: in the Methods heading under the Abstract section, the text \u2018multivariable logistic\u2019 should read as \u2018multivariable Cox\u2019, and it has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12865-025-00704-9","URL":"https:\/\/doi.org\/10.1186\/s12865-025-00704-9","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University.All of the patients provided written informed consent for enrollment in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}